PharmSource - M&A in the Contract Manufacturing Industry: Implications and Outlook - 2018 Edition

PharmSource - M&A in the Contract Manufacturing Industry: Implications and Outlook - 2018 Edition

Dec 2018 GlobalData Pharmaceutical52 Pages Price :
$ 4995
PharmSource - M&A in the Contract Manufacturing Industry: Implications and Outlook - 2018 Edition

Summary

This report is the 2nd edition of our analysis of Mergers and Acquisitions in the contract manufacturing industry. PharmSource is the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.

Scope

- Helps bio/pharmaceutical manufacturing, development, and supply chain executives understand the implications of M&A activity on their supply base and sourcing options.
- Helps executives at CMOs and associated contract services companies and investors to recognize the significance of M&A activities for the competitive dynamics of the industry and how company strategies must change to address the altering market.
- To gain insights that might enable predictions of the nature and implications of M&A activity in the next three to five years.

Reasons to buy

This 52-page report gives important, expert insight you wont find in any other source. 28 tables and figures throughout the report illustrate major points and trends. This report is required reading for -
- CMOs: market trends, strategic planning, competitive intelligence, performance benchmarking
- Bio/Pharma: supplier performance benchmarking, market trends, competitive intelligence
- Private equity and Stock analysts: target identification and analysis, portfolio company performance benchmarking.
Table of Contents
1. Executive Summary 4
2 Objectives and Methodology 5
3 Overview of M&A Activity 2015-2017 6
Target Characteristics 7
Acquirer Characteristics 11
4 Segment Close-Ups of M&A Activity, 2015-2017 15
Dose Manufacturing 15
API - Biologic 18
API - Small Molecule 19
Analytical Services 21
Formulation and Clinical Supplies Manufacturing 24
Packaging 26
5 Valuations 27
6 Facility Acquisitions 29
7 What It Means 36
8 The Outlook for M&A in the Manufacturing Services Industry 39
9 Notes on Methodology 41
10 Appendix 42
Service Acquisitions 2015-2017 42
Bibliography 49
Primary Research - Key Opinion Leaders Cited in this Report 49
About the Authors 50

List of Tables
Table 1: CMO Services Businesses Acquired as Part of Larger Deals, 2017 6
Table 2: Company Acquisitions by Target Service and Size, 2015-2017 9
Table 3: Company Acquisitions by Target Service and Ownership, 2015-2017 9
Table 4: Company Acquisitions by Target Market Scope and Size, 2015-2017 10
Table 5: Most Active Acquirers, 2015-2017 13
Table 6: Company Acquisitions of Dose Manufacturers, 2015-2017 16
Table 7: Company Acquisitions of API - Biologic Manufacturers, 2015-2017 19
Table 8: Company Acquisitions of API - Small Molecule Manufacturers, 2015-2017 20
Table 9: Company Acquisitions of Analytical Services, 2015-2017 22
Table 10: Company Acquisitions of Formulation Manufacturers, 2015-2017 25
Table 11: Company Acquisitions of Contract Packagers, 2015-2017 26
Table 12: Services Deals with Known Transaction Value and Multiples, 2015-2017 27
Table 13: Facility Acquisitions by CMOs, 2015-2017 33
Table 14: Most Active Acquirers, 2015-2017 36
Table 15: Acquisitions by PE Firms, 2015-2017 37
Table 16: Potential Targets: API - Biologic (Non-Cell and Gene Therapy) Service Providers 39
Table 17: Potential Targets: API - Biologic (Gene and Cell Therapy Only) Service Providers 40
Table 18: Service Acquisitions, 2015-2017 42

List of Figures
Figure 1: Company Acquisitions by Target Service Offering, 2015-2017 7
Figure 2: Company Acquisitions by Target Revenues, 2015-2017 8
Figure 3: Company Acquisitions by Target Ownership, 2015-2017 8
Figure 4: Acquisition Targets by Sophistication of Capabilities 11
Figure 5: Number of Acquisitions by Acquirers Core Business 12
Figure 6: Number of Acquisitions by Acquirer Ownership 13
Figure 7: Number of Acquisitions by Principal Acquirer Motivation 14
Figure 8: Dose Forms Manufactured by Acquired Dose Manufacturers 15
Figure 9: Pharma CMO Facility Acquisitions, 2015-2017 30

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 4995
$ 9990

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top